IoT Clinical Trials

Leveraging IoT & Emerging Technology to Digitally Transform Clinical Trials

July 22 & 23, 2021
Free ONLINE event for pharmaceutical & biotechnology professionals

Why Attend IoT Clinical Trials 2021:

Clinical Trial innovation has accelerated within the pharmaceutical and biotechnology sectors due to the recent pandemic, forcing the rapid digitalization and modernization of clinical trials.

However, with many moving parts, leading this transition can be complex, costly and labor intensive. With this in mind, this Virtual Summit will focus on leveraging IoT and emerging technology to modernize and digitally transform clinical trials.


  • Identify emerging technology that will optimize clinical R&D and facilitate decentralized, hybrid and virtual trials


  • Assess the value proposition for IoT in clinical trial innovation and develop a roadmap for successful technology implementation


  • Digitally optimize your clinical trials to enhance patient recruitment, engagement, adherence, retention and experience


  • Create and implement an effective data quality and analytics strategy that enhances connectivity, facilitates timely interventions and drives positive outcomes


  • Manage the mindset and culture shift required for digital empowerment and enable a successful transition towards decentralized clinical trials


    • Align your strategy with the evolving vendor landscape to create strong partnership-driven relationships with solutions providers

Learn from our expert speakers and panelists:

Craig Lipset
Decentralized Trials & Research Alliance (DTRA)

Isaac Rodriguez-Chavez
Senior Vice President, Scientific & Clinical Affairs Head, Global Centre of Excellence Strategy for Decentralized Clinical Trials
PRA Health Sciences

Michelle Crouthamel
Head, Digital Science

Robert “Joe” Mather
Executive Director, Head of Advanced Science Group

Bert Hartog
R&D Operations, Senior Director
Janssen Clinical Innovation, Johnson & Johnson

Robert J Boland
Executive Director, Digital Delivery & Data
CSL Behring

Jeremy Wyatt
Chief Executive Officer

Tim McCarthy
VP & Head of Digital Medicine & Translational Imaging

Vanessa Gertsen
Vice President, Study Operations Decentralized Trials
Care Access 

Valerie Markbreiter
Initiatives Leader

Phil Strong
Zymbit Inc.

IoT for Clinical Trials - Agenda

Thursday, July 22 2021


08:55 – 09:00 PT Opening Remarks from AMG World


09:00 – 10:00 PT Modernization and Digitalization of Clinical Trials


Jeremy Wyatt, Chief Executive Officer, ActiGraph



Craig Lipset, Co-Chair, Decentralized Trials & Research Alliance (DTRA)

Michelle Crouthamel, Managing Director, Digital Health Strategy & Implementation, AbbVie

Bert Hartog, R&D Operations, Senior Director, Janssen Clinical Innovation, Johnson & Johnson

Tim McCarthy, VP & Head of Digital Medicine & Translational Imaging, Pfizer


10:05 – 10:35 PT Future of Wearables, Digital Biomarkers, Endpoints and Remote Monitoring Tools


Jeremy Wyatt, Chief Executive Officer, ActiGraph



10:40 – 11:00 PT Technology Demonstration with Zymbit
Managing End-to-End Data Integrity and Privacy in Decentralized Clinical Trials


Phil Strong, CEO, Zymbit Inc.


11:00 – 11:30 PT Networking Break and Virtual Exhibition


11:30 – 12:00 PT Driving Innovation in Decentralized Clinical Trials with Fit-for-Purpose Technologies


Isaac Rodriguez-Chavez, Senior Vice President, Scientific & Clinical Affairs Head, Global Centre
of Excellence Strategy for Decentralized Clinical Trials, PRA Health Sciences


12:05 – 12:35 PT Managing Real-World Data and eSource in Decentralized Clinical Trials


12:40 – 13:15 PT Networking Lunch and Virtual Exhibition


13:15 – 14:15 PT Taking a Patient First Approach to Clinical Trial Innovation



Robert J Boland, Executive Director, Digital Delivery & Data, CSL Behring

Valerie Markbreiter, Initiatives Leader, Roche

Vanessa Gertsen, Vice President, Study Operations Decentralized Trials, Care Access Research


14:20 – 14:55 PT Implementing a Decentralized Clinical Trial at Scale for COVID-19 Observation


Robert “Joe” Mather, Executive Director, Head of Advanced Science Group, Pfizer


14:55 PT Close of Conference

Who should attend:

IoT Clinical Trials 2021 is designed for VP’s, Directors, Heads and Managers from:


  • Decentralized Clinical Trials
  • Hybrid & Virtual Clinical Trials
  • Clinical Operations / R&D Operations
  • Clinical Development
  • Clinical Trial Innovation
  • Outsource Clinical Trials
  • Healthcare Innovation / Healthcare Intelligence
  • Digital Health / Digital Medicine
  • Patient Engagement / Patient Outcomes / Patient Affairs
  • Regulatory / Clinical Affairs


Our sponsors include technology, service & solution providers specializing in:


  • ePRO / Electronic patient-reported outcome
  • eCOA / Electronic Clinical Outcome Assessment
  • eSource / Electronic Source Data Capture / DDC Direct Data Capture
  • eConsent / Digital Enrollment
  • Data Analytics Software & Platforms
  • Patient Experience Management Platforms / Mobile & Web Applications
  • Wearables / Biosensors
  • AI (Artificial Intelligence) / ML (Machine Learning)


Sponsorship Opportunities:

Recent disruption has continued to re-shape the conventional approach to networking, creating an opportunity to continue business within a virtual setting.


Our attendees are actively working through their operational and transformational challenges, but they also require support from dedicated solution providers who can offer guidance, expertise and technology to help solve unique business problems.


It is critical that the vendor community continues to support their customers through open discussions and information exchange; as well as nurture existing relationships and building a pipeline of new and valuable leads.


For more information on how we are uniquely placed to help you shape and deliver your message to your target audience, contact us now!


Simon Wright
Commercial Director